Your browser doesn't support javascript.
loading
The Human Melanoma Proteome Atlas-Complementing the melanoma transcriptome.
Betancourt, Lazaro Hiram; Gil, Jeovanis; Sanchez, Aniel; Doma, Viktória; Kuras, Magdalena; Murillo, Jimmy Rodriguez; Velasquez, Erika; Çakir, Ugur; Kim, Yonghyo; Sugihara, Yutaka; Parada, Indira Pla; Szeitz, Beáta; Appelqvist, Roger; Wieslander, Elisabet; Welinder, Charlotte; de Almeida, Natália Pinto; Woldmar, Nicole; Marko-Varga, Matilda; Eriksson, Jonatan; Pawlowski, Krzysztof; Baldetorp, Bo; Ingvar, Christian; Olsson, Håkan; Lundgren, Lotta; Lindberg, Henrik; Oskolas, Henriett; Lee, Boram; Berge, Ethan; Sjögren, Marie; Eriksson, Carina; Kim, Dasol; Kwon, Ho Jeong; Knudsen, Beatrice; Rezeli, Melinda; Malm, Johan; Hong, Runyu; Horvath, Peter; Szász, A Marcell; Tímár, József; Kárpáti, Sarolta; Horvatovich, Peter; Miliotis, Tasso; Nishimura, Toshihide; Kato, Harubumi; Steinfelder, Erik; Oppermann, Madalina; Miller, Ken; Florindi, Francesco; Zhou, Quimin; Domont, Gilberto B.
Affiliation
  • Betancourt LH; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Gil J; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Sanchez A; Section for Clinical Chemistry, Department of Translational Medicine, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.
  • Doma V; 2nd Department of Pathology, Semmelweis University, Budapest, Hungary.
  • Kuras M; Department of Dermatology, Venerology and Dermatooncology, Semmelweis University, Budapest, Hungary.
  • Murillo JR; Section for Clinical Chemistry, Department of Translational Medicine, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.
  • Velasquez E; Department of Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
  • Çakir U; Section for Clinical Chemistry, Department of Translational Medicine, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.
  • Kim Y; Department of Dermatology, Venerology and Dermatooncology, Semmelweis University, Budapest, Hungary.
  • Sugihara Y; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Parada IP; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Szeitz B; Section for Clinical Chemistry, Department of Translational Medicine, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.
  • Appelqvist R; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
  • Wieslander E; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Welinder C; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • de Almeida NP; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Woldmar N; Chemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Marko-Varga M; Clinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lund University, Lund, Sweden.
  • Eriksson J; Chemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Pawlowski K; Clinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lund University, Lund, Sweden.
  • Baldetorp B; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Ingvar C; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Olsson H; Department of Dermatology, Venerology and Dermatooncology, Semmelweis University, Budapest, Hungary.
  • Lundgren L; Department of Molecular Biology, University of Texas Southwestern medical center, Texas.
  • Lindberg H; Department of Biochemistry and Microbiology, Warsaw University of Life Sciences, Warszawa, Poland.
  • Oskolas H; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Lee B; SUS University hospital Lund, Lund, Sweden.
  • Berge E; Department of Surgery, Clinical Sciences, Lund University, Lund, Sweden.
  • Sjögren M; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Eriksson C; SUS University hospital Lund, Lund, Sweden.
  • Kim D; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Kwon HJ; SUS University hospital Lund, Lund, Sweden.
  • Knudsen B; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Rezeli M; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Malm J; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Hong R; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Horvath P; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Szász AM; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Tímár J; Chemical Genomics Global Research Lab, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea.
  • Kárpáti S; Chemical Genomics Global Research Lab, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea.
  • Horvatovich P; Department of Pathology, University of Utah, Salt Lake City, Utah.
  • Miliotis T; Clinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lund University, Lund, Sweden.
  • Nishimura T; Section for Clinical Chemistry, Department of Translational Medicine, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.
  • Kato H; Department of Biochemistry and Molecular Pharmacology, Institute for Systems Genetics, New York University Grossman School of Medicine, New York City, New York.
  • Steinfelder E; Synthetic and Systems Biology Unit, Biological Research Center, Szeged, Hungary.
  • Oppermann M; Department of Bioinformatics, Semmelweis University, Budapest, Hungary.
  • Miller K; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
  • Florindi F; 2nd Department of Pathology, Semmelweis University, Budapest, Hungary.
  • Zhou Q; Department of Dermatology, Venerology and Dermatooncology, Semmelweis University, Budapest, Hungary.
  • Domont GB; Faculty of Science and Engineering, Department of Analytical Biochemistry, University of Groningen, Groningen, The Netherlands.
Clin Transl Med ; 11(7): e451, 2021 07.
Article in En | MEDLINE | ID: mdl-34323402
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proteome / Proteomics / Transcriptome / Melanoma Limits: Humans Language: En Journal: Clin Transl Med Year: 2021 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proteome / Proteomics / Transcriptome / Melanoma Limits: Humans Language: En Journal: Clin Transl Med Year: 2021 Document type: Article Affiliation country: